SCHEMBL751681

SCHEMBL751681

CC(C)c1ccccc1S(=O)(=O)CBr

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
HSD11B1 P28845 1/20 0.41
POLB P06746 1/20 0.39
PLCG1 P19174 1/20 0.38
GABRA1 P14867 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
GABRB2 P47870 2/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
FAAH O00519 2/20 0.34
CYP3A4 P08684 2/20 0.34
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
GABRB1 P18505 1/20 0.34
PTGS1 P23219 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10179614 0.84 PSIP1 (0.45) L3MBTL1HSD11B1POLBPLCG1GABRA1
SCHEMBL1106525 0.79 L3MBTL1 (0.52) L3MBTL1HSD11B1POLBGABRA1CA1
SCHEMBL10180179 0.78 TSHR (0.53) L3MBTL1HSD11B1POLBCA1CA2
SCHEMBL10180861 0.78 HSD11B1 (0.49) L3MBTL1HSD11B1POLBPLCG1GABRA1
SCHEMBL9379437 0.77 HSD11B1 (0.54) L3MBTL1HSD11B1POLBGABRA1CA1
SCHEMBL28542040 0.77 MMP2 (0.46) L3MBTL1HSD11B1GABRA1GABRB2LMNA
SCHEMBL10179973 0.77 ALDH1A1 (0.45) L3MBTL1HSD11B1POLBGABRA1CA1
SCHEMBL9711267 0.75 KMT2A (0.41) L3MBTL1HSD11B1POLBGABRA1CA1
SCHEMBL12812603 0.74 L3MBTL1 (0.46) L3MBTL1HSD11B1POLBGABRA1CA1
SCHEMBL1106519 0.74 CA1 (0.53) L3MBTL1HSD11B1POLBGABRA1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M L3MBTL1 1037/4885HSD11B1 462/4885POLB 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.